PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
CPHI
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper
news

Wockhardt starts manufacturing and R&D facility in Dubai

With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a‘state-of-the-art’ manufacturing facili...
Continue Reading →
news

SanBio Receives $20 Million Grant From CIRM

CIRM is an agency of the State of California formed to accelerate the progress of regenerative medicine through a highly competitive grant program. Prospective grants...
Continue Reading →
news

Sales of Roche new drugs are surging. Will that be enough?

Quickening sales of Roche's newer medicines offset the impact of rising biosimilar competition during the second quarter, helping to drive a 7% year-over-year jump...
Continue Reading →
news

Gilead CEO Milligan out ahead of turnaround bid

In an unexpected statement ahead of its second quarter earnings release Wednesday evening, Gilead Sciences said its well-liked CEO John Milligan will step down and...
Continue Reading →
news

Positive Alzheimer’s results from Biogen, Eisai spark ‘cautious optimism’

Biogen and partner Eisai announced Wednesday that a once-failed experimental drug for Alzheimer's disease slowed cognitive decline in patients with early forms of ...
Continue Reading →
news

GSK signs $300M genetic testing deal

GSK and 23andMe will also work on earlier-stage programs. The partners plan to use 23andMe’s data to jointly discover drug targets. GlaxoSmithKline has made a $300 m...
Continue Reading →
news

WuXi STA’s Jinshan site passes fourth U.S. FDA inspection

The Jinshan facility is dedicated to the manufacture of small molecule innovative APIs and advanced intermediates, from kilo to metric ton scale – from preclinical an...
Continue Reading →
news

Innovent receives IND approval to initiate Clinical Trials in China

Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company tha...
Continue Reading →
news

FIND, DNDi to support Malaysian MoH for approaching HCV

It forms part of a larger FIND project known as Hepatitis C Elimination through Access to Diagnostics (HEAD-Start), supported by Unitaid. The Foundation for Innovat...
Continue Reading →
news

Now your smartphone camera can perform clinical urinalysis at home

U.S. FDA Grants Landmark Class II Approval for Clinical Grade Smartphone Testing - Healthy.io’s Dip.io Urinalysis Israel based Healthy.io, the first company in the ...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience